Keyphrases
Length of Stay
100%
Community-acquired Pneumonia
87%
Lung Fibrosis
87%
Academic Hospital
87%
Radiopaque Hydrogel
87%
CD4+ T Cells
87%
Value-based Care
87%
Skilled nursing Facility
87%
Global Budget Revenue
87%
Electronic Transducer
87%
Inpatient-only List
87%
Pleural Pressure
87%
Mammalian Target of Rapamycin (mTOR)
87%
Transitional Care
87%
T Cells
87%
Interleukin-17 (IL-17)
87%
T Helper 17 (Th17)
87%
Duration of Therapy
87%
Post-acute Care
87%
Academic Health System
87%
Antimicrobial Stewardship Program
87%
Fibrosis
65%
Digital Manometer
62%
Thoracentesis
62%
Aneurysm Model
52%
Pulmonary Fibrosis
43%
Chronic Inflammation
43%
Increased Mortality
43%
Antibiotic Duration
37%
Handheld
37%
U-tube
37%
Performance Measures
25%
Neutrophils
21%
Hospital Capacity
21%
Provider Networks
21%
Network Applications
21%
Lung
21%
Collaborative Framework
21%
Rehospitalization
21%
Incurable Disease
21%
Hospitalization
21%
Preferred Providers
21%
Bleomycin
21%
Inpatient Length of Stay
21%
Bleomycin-induced Pulmonary Fibrosis
21%
Rare Occurrence
21%
Financial Pressure
21%
Readmission
21%
Data Reporting
21%
Referral Networks
21%
Medicine and Dentistry
Medicare
100%
Antiinfective Agent
87%
Treatment Duration
87%
Patient Care
87%
Community-Acquired Pneumonia
87%
Health System
87%
Orthopedics
87%
Hospital Efficiency
87%
Outpatient
87%
Internal Medicine
87%
Quality Improvement
87%
Subacute Care
87%
Awareness
43%
Disease Severity
43%
Checklist
43%
Diagnosis-Related Group
43%
Antibiotic Therapy
37%
Medicine
29%
Patient Referral
29%
Antibiotics
25%
Pathogen
12%
Prospective Study
12%
Surgery
10%
Health Service
10%
Orthopedic Surgeon
10%
Health Care Cost
10%
Pharmacology, Toxicology and Pharmaceutical Science
Fibrosing Alveolitis
87%
Fibrosis
87%
Saccular Aneurysm
87%
Lung Fibrosis
87%
Coughing
87%
Community Acquired Pneumonia
87%
Antiinfective Agent
87%
Endoleak
43%
Chronic Inflammation
43%
Antibiotic Therapy
37%
Disease
27%
Wound Healing
27%
Bleomycin
21%
Bleomycin-Induced Pulmonary Fibrosis
21%
Cytokine
21%
Epileptic Absence
21%
Antibiotics
12%
Antibiotic Agent
12%
Prospective Study
12%
Infectious Agent
12%
Symptom
10%
Dyspnea
5%
Scar Formation
5%
Disease Severity
5%
Respiratory Tract Inflammation
5%
Interferon
5%
Antitussive Agent
5%
Side Effect
5%
Asthma
5%
Gastroesophageal Reflux
5%
Thalidomide
5%
Disease Exacerbation
5%
Cohort Study
5%
Clinical Trial
5%
Prednisolone
5%
Syndrome
5%
Placebo
5%